Stocks Teva Pharmaceutical Industries Ltd


  • Cramer makes the call on viewers' favorite stocks.

  • Many companies have reported earnings that have surprised to the upside, but how will they perform for the rest of the year? Dan Genter, CEO of RNC Genter Capital Management shared his insight and investment strategy.

  • With UnitedHealthcare due to report earnings on Tuesday, Wall Street is taking close notice of late developments in the area of healthcare reform.

  • Michael Jackson

    The Food and Drug Administration today announced that Teva Pharmaceutical Industries is voluntarily recalling two lots of the anesthetic Propofol because there are higher levels of potentially fatal endotoxins...Propofol is the same drug that was reportedly found in Michael Jackson’s house.

  • Bugs Bunny

    Could a carrot-chomping Bugs Bunny become a drug pitchman? Well, maybe, if the small Israeli company Protalix BioTherapeutics could pay Warner Brothers enough money for Bugs' services.

  • A New York Stock Exchange trader.

    The Fed's decision to keep interest rates low because of the weak economy caused a stock rally to fade and heightened concerns that Fed Chairman Bernanke's "green shoots" were turning brown.

  • piggy_bank.jpg

    "Slow growth and higher taxes—that's not a recipe for higher stocks," says one economist. "The threat of deflationary spiral...that's what spooked the market."

  • graphic_word_ofthe_street.jpg

    The Dow and S&P 500 gained on Thursday as data on the job market and regional manufacturing revived hopes that the economy may be stabilizing.

  • graphic_fast_money.jpg

    As healthcare lands squarely in Washington’s sights, how should you play the sector?

  • Jon Najarian, co-founder of breaks down the M&A with Scott Wapner on Tuesday’s Fast Money Final Call.

  • CNBC’s Mike Huckman is keeping a close eye on Big Pharma earnings. And he suggests you do the same - because he's spotted a devil the details.

  • Cramer makes the call on viewers' favorite stocks.

  • Stock and options traders are piling into Biogen Idec on speculation that the drug maker could be a takeover target. About 75,000 options contracts traded on the name, more than 10 times the average over the last 20 session...

  • graphic_word_ofthe_street.jpg

    Stocks rose on Friday for the 4th day in a row, with the Dow closing out its best four-week winning streak since 1933.

  • graphic_fast_money.jpg

    Patsy from Virginia writes, “Karen, great calls on Foot Locker and Flowserve. I’m up over 35%. Do you think there’s still room to run here or should I sell and wait for a pullback?"

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you Monday's best trades, right now!

  • Ritz Carlton Naples

    At the risk of offending our gracious hosts here at the Generic Pharmaceutical Association's Silver Anniversary Meeting, I wanted to talk about the seemingly incongruous venue for the event.

  • Despite the ongoing recession, generic drug makers like Teva Pharmaceutical and Watson Pharmaceutical have been outperforming in the broader market. CEOs William Marth and Paul Bisaro both expect to see further growth.

  • Dan Genter thinks the markets may be bumping along the bottom until the end of this year or the beginning of 2010, but then, equities will be the place to be, and now is the time to get positioned.  He feels the framework for recovery is now being built.

  • Which firms are racing to the forefront of this bold new science?